NCT00742664

Brief Summary

Obsessive-compulsive (OC) symptoms are often present among youth with Prader-Willi Syndrome (PWS). They are also associated with considerable problems in the daily functioning of the child and his/her family. Although medication and behavioral treatments exist that target OC symptoms among youth without PWS, these treatments have not been thoroughly adapted for this population nor scientifically tested. Although medication has been helpful in addressing OC symptoms in several published case reports, the associated efficacy is modest and the potential for side effects is a realistic concern. Given that behavioral treatment for OC symptoms has superior efficacy to pharmacotherapy in youth without PWS without the accompanying risk for adverse side effects, it follows that an adapted version of behavioral therapy may hold promise in treating clinically problematic OC symptoms in youth with PWS. Thus, the purpose of the proposed grant is to develop and pilot-test a behavioral treatment for OC symptoms for use in youth with PWS. This study will allow us to develop and test a treatment protocol aimed at reducing OC symptoms that are clinically problematic and negatively impact functioning and quality of life in the child and his/her family.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
24

participants targeted

Target at P25-P50 for phase_1

Timeline
Completed

Started Sep 2008

Typical duration for phase_1

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 26, 2008

Completed
2 days until next milestone

First Posted

Study publicly available on registry

August 28, 2008

Completed
4 days until next milestone

Study Start

First participant enrolled

September 1, 2008

Completed
2.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2011

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2011

Completed
Last Updated

August 8, 2011

Status Verified

July 1, 2011

Enrollment Period

2.8 years

First QC Date

August 26, 2008

Last Update Submit

August 4, 2011

Conditions

Keywords

Prader-Willi SyndromeCompulsive behaviorHoardingObsessive-compulsive disorderChildrenTreatmentgeneticallyconfirmeddiagnosis

Outcome Measures

Primary Outcomes (1)

  • Children's Yale-Brown Obsessive Compulsive Scale (CY-BOCS; Scahill et al., 1997).

    Baseline, Mid-Treatment, Post-treatment

Secondary Outcomes (1)

  • Clinical Global Improvement (CGI; Guy, 1976).

    Mid- and Post-treatment

Study Arms (2)

1

EXPERIMENTAL

Will receive 12 sessions of twice weekly psychotherapy targeting obsessive-compulsive symptoms.

Behavioral: Cognitive-behavioral therapy

2

PLACEBO COMPARATOR
Behavioral: Wait-list control

Interventions

The manual is informed by behavioral principles and provides a structured, replicable manner of treating OC symptoms in youth with PWS. The treatment is individual in nature, includes a strong family component (i.e., teaching parents to be their child's coach/therapist), and lasts for approximately 12 sessions, held in a twice-weekly format. In addition, the protocol includes several specific components: education about OC symptoms (i.e., etiology, behavioral function, etc.), developing a hierarchy of rituals to target, exposure and response prevention exercises, promoting adaptive familial responses to child behaviors, and relapse prevention and problem solving future situations.

1

The subject will not receive active treatment during this interval.

2

Eligibility Criteria

Age6 Years - 17 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • The child must have a genetically confirmed diagnosis of PWS;
  • CY-BOCS Compulsion Score ≥ 8. The Compulsion Scale Score is being used as youth with PWS may have difficulty understanding or identifying the connection between obsessional thoughts and subsequent rituals. Therefore, use of the Total Score may provide an inaccurate depiction of symptoms (Storch et al., 2005);
  • Stable on any psychotropic medications for 8 weeks prior to study entry;
  • Between the ages of 6 and 17 years as the present measures are valid for use in this age span;
  • At least one parent available to accompany the child to all sessions; and
  • English speaking.

You may not qualify if:

  • Current suicidal intent or risk;
  • A positive diagnosis in the caregiver of mental retardation, psychosis, or other psychiatric conditions that would limit their ability to understand psychotherapy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

All Children's Hospital

St. Petersburg, Florida, 33701, United States

Location

MeSH Terms

Conditions

Prader-Willi SyndromeObsessive-Compulsive DisorderCompulsive BehaviorHoardingDisease

Interventions

Cognitive Behavioral Therapy

Condition Hierarchy (Ancestors)

Intellectual DisabilityNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesAbnormalities, MultipleCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesChromosome DisordersGenetic Diseases, InbornImprinting DisordersObesityOverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesAnxiety DisordersMental DisordersImpulsive BehaviorBehaviorPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Behavior TherapyPsychotherapyBehavioral Disciplines and Activities

Study Officials

  • Eric Storch, Ph.D.

    University of South Florida

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 1
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

August 26, 2008

First Posted

August 28, 2008

Study Start

September 1, 2008

Primary Completion

July 1, 2011

Study Completion

July 1, 2011

Last Updated

August 8, 2011

Record last verified: 2011-07

Locations